Hepatocyte nuclear factor 4α regulation of bile acid and drug metabolism

Bibliography

• Committee of Nuclear Receptor Nomenclature. A unified nomenclature system for the nuclear receptor superfamily. Cell 1999;97(2):161-3
   PubMed Web of Science ®Google Scholar
• Sladek FM, Zhong WM, Lai E, Darnell JE Jr. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 1990;4(12B):2353-65
   PubMed Web of Science ®Google Scholar
• Drewes T, Senkel S, Holewa B, Ryffel GU. Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes. Mol Cell Biol 1996;16(3):925-31
   PubMed Web of Science ®Google Scholar
• Hertz R, Magenheim J, Berman I, Bar-Tana J. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α. Nature 1998;392(6675):512-6
   PubMed Web of Science ®Google Scholar
• Schroeder F, Huang H, Hostetler HA, et al. Stability of fatty acyl-coenzyme A thioester ligands of hepatocyte nuclear factor-4α and peroxisome proliferator-activated receptor-alpha. Lipids 2005;40(6):559-68
   PubMed Web of Science ®Google Scholar
• Dhe-Paganon S, Duda K, Iwamoto M, et al. Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand. J Biol Chem 2002;277(41):37973-6
   PubMed Web of Science ®Google Scholar
• Wisely GB, Miller AB, Davis RG, et al. Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure (Camb) 2002;10(9):1225-34
   PubMed Web of Science ®Google Scholar
• Sladek FM, Seidel SD. Hepatocyte nuclear factor 4alpha. In: Burris TP, McCabe E, editors, Nuclear Receptors and Genetic Diseases, Academic Press, London; 2001
   Google Scholar
• Odom DT, Zizlsperger N, Gordon DB, et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004;303(5662):1378-81
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ. Regulation of hepatocyte nuclear factor 4α-mediated transcription. Drug Metab Pharmacokinet 2008;23(1):2-7
   PubMed Web of Science ®Google Scholar
• Duncan SA, Manova K, Chen WS, et al. Expression of transcription factor HNF-4 in the extraembryonic endoderm, gut, and nephrogenic tissue of the developing mouse embryo: HNF-4 is a marker for primary endoderm in the implanting blastocyst. Proc Natl Acad Sci USA 1994;91(16):7598-602
   PubMed Web of Science ®Google Scholar
• Zaret KS. Liver specification and early morphogenesis. Mech Dev 2000;92(1):83-8
   PubMed Web of Science ®Google Scholar
• Zaret KS. Regulatory phases of early liver development: paradigms of organogenesis. Nat Rev 2002;3(7):499-512
   Google Scholar
• Costa RH, Kalinichenko VV, Holterman AX, Wang X. Transcription factors in liver development, differentiation, and regeneration. Hepatology 2003;38(6):1331-47
   PubMed Web of Science ®Google Scholar
• Xanthopoulos KG, Prezioso VR, Chen WS, et al. The different tissue transcription patterns of genes for HNF1, C/EBP, HNF3, and HNF4 protein factors that govern liver-specific transcription. Proc Natl Acad Sci USA 1991;88:3807-11
   PubMed Web of Science ®Google Scholar
• Rausa F, Samadani U, Ye H, et al. The cut-homeodomain transcriptional activator HNF-6 is coexpressed with its target gene HNF-3 beta in the developing murine liver and pancreas. Dev Biol 1997;192(2):228-46
   PubMed Web of Science ®Google Scholar
• Boj SF, Parrizas M, Maestro MA, Ferrer J. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc Natl Acad Sci USA 2001;98(25):14481-6
   PubMed Web of Science ®Google Scholar
• Thomas H, Jaschkowitz K, Bulman M, et al. A distant upstream promoter of the HNF-4α gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum Mol Genet 2001;10(19):2089-97
   PubMed Web of Science ®Google Scholar
• Eeckhoute J, Moerman E, Bouckenooghe T, et al. Hepatocyte nuclear factor 4α isoforms originated from the P1 promoter are expressed in human pancreatic beta-cells and exhibit stronger transcriptional potentials than P2 promoter-driven isoforms. Endocrinology 2003;144(5):1686-94
   PubMed Web of Science ®Google Scholar
• Chen WS, Manova K, Weinstein DC, et al. Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Gen Dev 1994;8(20):2466-77
   PubMed Web of Science ®Google Scholar
• Hayhurst GP, Lee YH, Lambert G, et al. Hepatocyte nuclear factor 4α (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 2001;21(4):1393-403
   PubMed Web of Science ®Google Scholar
• Inoue Y, Yu AM, Yim SH, et al. Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4α. J Lipid Res 2006;47(1):215-27
   PubMed Web of Science ®Google Scholar
• Rhee J, Inoue Y, Yoon JC, et al. Regulation of hepatic fasting response by PPARγ coactivator-1α (PGC-1α): requirement for hepatocyte nuclear factor 4α in gluconeogenesis. Proc Natl Acad Sci USA 2003;100(7):4012-7
   PubMed Web of Science ®Google Scholar
• Wang H, Maechler P, Antinozzi PA, et al. Hepatocyte nuclear factor 4α regulates the expression of pancreatic beta-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion. J Biol Chem 2000;275(46):35953-9
   PubMed Web of Science ®Google Scholar
• Miura A, Yamagata K, Kakei M, et al. Hepatocyte nuclear factor-4α is essential for glucose-stimulated insulin secretion by pancreatic beta-cells. J Biol Chem 2006;281(8):5246-57
   PubMed Web of Science ®Google Scholar
• Gupta RK, Vatamaniuk MZ, Lee CS, et al. The MODY1 gene HNF-4α regulates selected genes involved in insulin secretion. J Clin Invest 2005;115(4):1006-15
   PubMed Web of Science ®Google Scholar
• Ahn SH, Shah YM, Inoue J, et al. Hepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel disease. Inflamm Bowel Dis 2008;14(7):908-20
   PubMed Web of Science ®Google Scholar
• Yamagata K, Furuta H, Oda N, et al. Mutations in the hepatocyte nuclear factors-4α gene in maturity-onset diabetes of the young (MODY1). Nature 1996;384:458-60
   PubMed Web of Science ®Google Scholar
• Stoffel M, Duncan SA. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4α regulates expression of genes required for glucose transport and metabolism. Proc Natl Acad Sic USA 1997;94:13209-14
   PubMed Web of Science ®Google Scholar
• Lausen J, Thomas H, Lemm I, et al. Naturally occurring mutations in the human HNF4alpha gene impair the function of the transcription factor to a varying degree. Nucleic Acids Res 2000;28(2):430-7
   PubMed Web of Science ®Google Scholar
• Ryffel GU. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J Mol Endocrinol 2001;27(1):11-29
   PubMed Web of Science ®Google Scholar
• Navas MA, Munoz-Elias EJ, Kim J, et al. Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q). Diabetes 1999;48(7):1459-65
   PubMed Web of Science ®Google Scholar
• Sladek FM, Dallas-Yang Q, Nepomuceno L. MODY1 mutation Q268X in hepatocyte nuclear factor 4alpha allows for dimerization in solution but causes abnormal subcellular localization. Diabetes 1998;47(6):985-90
   PubMed Web of Science ®Google Scholar
• Hani EH, Suaud L, Boutin P, et al. A missense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus. J Clin Invest 1998;101(3):521-6
   PubMed Web of Science ®Google Scholar
• Tokunaga A, Horikawa Y, Fukuda-Akita E, et al. A common P2 promoter polymorphism of the hepatocyte nuclear factor-4 gene is associated with insulin secretion in non-obese Japanese with Type 2 diabetes. Endocr J 2008. [Epub ahead of print]
   Google Scholar
• Shih DQ, Dansky HM, Fleisher M, et al. Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes 2000;49(5):832-7
   PubMed Web of Science ®Google Scholar
• Jiang G, Nepomuceno L, Hopkins K, Sladek FM. Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors. Mol Cell Biol 1995;15:5131-43
   PubMed Web of Science ®Google Scholar
• Sladek FM, Ruse MD Jr, Nepomuceno L, et al. Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1. Mol Cell Biol 1999;19(10):6509-22
   PubMed Web of Science ®Google Scholar
• Dell H, Hadzopoulou-Cladaras M. CREB-binding protein is a transcriptional coactivator for hepatocyte nuclear factor-4 and enhances apolipoprotein gene expression. J Biol Chem 1999;274(13):9013-21
   PubMed Web of Science ®Google Scholar
• Wang JC, Stafford JM, Granner DK. SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. J Biol Chem 1998;273(47):30847-50
   PubMed Web of Science ®Google Scholar
• Surapureddi S, Rana R, Reddy JK, Goldstein JA. Nuclear receptor coactivator 6 mediates the synergistic activation of human cytochrome P-450 2C9 by the constitutive androstane receptor and hepatic nuclear factor-4α. Mol Pharmacol 2008;74(3):913-23
   PubMed Web of Science ®Google Scholar
• Yoon JC, Puigserver P, Chen G, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001;413(6852):131-8
   PubMed Web of Science ®Google Scholar
• Rhee J, Ge H, Yang W, et al. Partnership of PGC-1α and HNF4α in the regulation of lipoprotein metabolism. J Biol Chem 2006;281(21):14683-90
   PubMed Web of Science ®Google Scholar
• Zhang Y, Castellani LW, Sinal CJ, et al. Peroxisome proliferator-activated receptor-gamma coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Gen Dev 2004;18(2):157-69
   PubMed Web of Science ®Google Scholar
• Li T, Chiang JY. Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4α and coactivators, and suppression of small heterodimer partner gene expression. Drug Metab Dispos 2006;34(5):756-64
   PubMed Web of Science ®Google Scholar
• Ding X, Lichti K, Kim I, et al. Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha. J Biol Chem 2006;281(36):26540-51
   PubMed Web of Science ®Google Scholar
• Finck BN, Kelly DP. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 2006;116(3):615-22
   PubMed Web of Science ®Google Scholar
• Knutti D, Kralli A. PGC-1, a versatile coactivator. Trends Endocrinol Metab 2001;12(8):360-5
   PubMed Web of Science ®Google Scholar
• Guo H, Gao C, Mi Z, et al. Characterization of the PC4 binding domain and its interactions with HNF4α. J Biochem (Tokyo) 2007;141(5):635-40
   PubMed Web of Science ®Google Scholar
• Torres-Padilla ME, Sladek FM, Weiss MC. Developmentally regulated N-terminal variants of the nuclear receptor hepatocyte nuclear factor 4α mediate multiple interactions through coactivator and corepressor-histone deacetylase complexes. J Biol Chem 2002;277(47):44677-87
   PubMed Web of Science ®Google Scholar
• Lee YK, Dell H, Dowhan DH, et al. The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression. Mol Cell Biol 2000;20(1):187-95
   PubMed Web of Science ®Google Scholar
• Zhang M, Chiang JY. Transcriptional regulation of the human sterol 12α-hydroxylase gene (CYP8B1): roles of heaptocyte nuclear factor 4α in mediating bile acid repression. J Biol Chem 2001;276(45):41690-9
   PubMed Web of Science ®Google Scholar
• Hatzis P, Talianidis I. Regulatory mechanisms controlling human hepatocyte nuclear factor 4α gene expression. Mol Cell Biol 2001;21(21):7320-30
   PubMed Web of Science ®Google Scholar
• Mietus-Snyder M, Sladek FM, Ginsburg GS, et al. Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells. Mol Cell Biol 1992;12(4):1708-18
   PubMed Web of Science ®Google Scholar
• Ktistaki E, Talianidis I. Chicken ovalbumin upstream promoter transcription factors act as auxiliary cofactors for hepatocyte nuclear factor 4 and enhance hepatic gene expression. Mol Cell Biol 1997;17:2790-7
   PubMed Web of Science ®Google Scholar
• Kang S, Spann NJ, Hui TY, Davis RA. ARP-1/COUP-TF II determines hepatoma phenotype by acting as both a transcriptional repressor of microsomal triglyceride transfer protein and an inducer of CYP7A1. J Biol Chem 2003;278(33):30478-86
   PubMed Web of Science ®Google Scholar
• Stroup D, Chiang JYL. HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7α-hydroxylase gene (CYP7A). J Lipid Res 2000;41:1-11
   PubMed Web of Science ®Google Scholar
• Malik S, Karathanasis S. Transcriptional activation by the orphan nuclear receptor ARP-1. Nucleic Acids Res 1995;23(9):1536-43
   PubMed Web of Science ®Google Scholar
• Chiang JYL, Kimmel R, Weinberger C, Stroup D. FXR responds to bile acids and represses cholesterol 7α-hydroxylase gene (CYP7A1) transcription. J Biol Chem 2000;275:10918-24
   PubMed Web of Science ®Google Scholar
• Chou WC, Prokova V, Shiraishi K, et al. Mechanism of a transcriptional cross talk between transforming growth factor-beta-regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor-4. Mol Biol Cell 2003;14(3):1279-94
   PubMed Web of Science ®Google Scholar
• Kardassis D, Pardali K, Zannis VI. SMAD proteins transactivate the human ApoCIII promoter by interacting physically and functionally with hepatocyte nuclear factor 4. J Biol Chem 2000;275(52):41405-14
   PubMed Web of Science ®Google Scholar
• Maeda Y, Hwang-Verslues WW, Wei G, et al. Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene. Biochem J 2006;400(2):303-13
   PubMedGoogle Scholar
• Maeda Y, Seidel SD, Wei G, et al. Repression of hepatocyte nuclear factor 4alpha tumor suppressor p53: involvement of the ligand-binding domain and histone deacetylase activity. Mol Endocrinol 2002;16(2):402-10
   PubMedGoogle Scholar
• Hirota K, Daitoku H, Matsuzaki H, et al. Hepatocyte nuclear factor-4 is a novel downstream target of insulin via FKHR as a signal-regulated transcriptional inhibitor. J Biol Chem 2003;278(15):13056-60
   PubMed Web of Science ®Google Scholar
• Li T, Kong X, Owsley E, et al. Insulin regulation of cholesterol 7α-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c. J Biol Chem 2006;281(39):28745-54
   PubMed Web of Science ®Google Scholar
• Hirota K, Sakamaki JI, Ishida J, et al. A combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding. J Biol Chem 2008;283(47):32432-41
   PubMed Web of Science ®Google Scholar
• Matsuzaki H, Daitoku H, Hatta M, et al. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc Natl Acad Sci USA 2003;100(20):11285-90
   PubMed Web of Science ®Google Scholar
• Sanyal S, Bavner A, Haroniti A, et al. Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis. Proc Natl Acad Sci USA 2007;104(40):15665-70
   PubMed Web of Science ®Google Scholar
• Viollet B, Kahn A, Raymondjean M. Protein kinase A-dependent phosphorylation modulates DNA-binding activity of hepatocyte nuclear factor 4. Mol Cell Biol 1997;17:4208-19
   PubMed Web of Science ®Google Scholar
• Guo H, Gao C, Mi Z, et al. Phosphorylation of Ser158 regulates inflammatory redox-dependent hepatocyte nuclear factor-4α transcriptional activity. Biochem J 2006;394(Pt 2):379-87
   PubMed Web of Science ®Google Scholar
• Reddy S, Yang W, Taylor DG, et al. Mitogen-activated protein kinase regulates transcription of the ApoCIII gene. Involvement of the orphan nuclear receptor HNF4. J Biol Chem 1999;274(46):33050-6
   PubMed Web of Science ®Google Scholar
• Jahan A, Chiang JY. Cytokine regulation of human sterol 12α-hydroxylase (CYP8B1) gene. Am J Physiol 2004;288:G685-95
   Web of Science ®Google Scholar
• Hong YH, Varanasi US, Yang W, Leff T. AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J Biol Chem 2003;278(30):27495-501
   PubMed Web of Science ®Google Scholar
• Sun K, Montana V, Chellappa K, et al. Phosphorylation of a conserved serine in the deoxyribonucleic acid binding domain of nuclear receptors alters intracellular localization. Mol Endocrinol 2007;21(6):1297-311
   PubMedGoogle Scholar
• Ktistaki E, Ktistaki T, Papadogeorgaki E, Talianidis I. Recruitment of hepatocyte nuclear factor 4 into specific intranuclear compartiments depends on tyrosine phosphorylation that affects its DNA-binding and transactivation potential. Proc Natl Acad Sci USA 1995;92:9876-80
   PubMed Web of Science ®Google Scholar
• Soutoglou E, Talianidis I. Coordination of PIC assembly and chromatin remodeling during differentiation-induced gene activation. Science 2002;295(5561):1901-4
   PubMed Web of Science ®Google Scholar
• Soutoglou E, Katrakili N, Talianidis I. Acetylation regulates transcription factor activity at multiple levels. Mol Cell 2000;5(4):745-51
   PubMed Web of Science ®Google Scholar
• Chiang JY. Regulation of bile acid synthesis. Front Biosci 1998;3:d176-93
   PubMedGoogle Scholar
• Chiang JY. Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev 2002;23(4):443-63
   PubMed Web of Science ®Google Scholar
• Chiang JY. Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J Hepatol 2004;40(3):539-51
   PubMed Web of Science ®Google Scholar
• Crestani M, Sadeghpour A, Stroup D, et al. Transcriptional activation of the cholesterol 7α -hydroxylase gene (CYP7A) by nuclear hormone receptors. J Lipid Res 1998;39:2192-200
   PubMed Web of Science ®Google Scholar
• Chiang JY, Stroup D. Identification and characterization of a putative bile acid-responsive element in cholesterol 7α-hydroxylase gene promoter. J Biol Chem 1994;269(26):17502-7
   PubMed Web of Science ®Google Scholar
• Stroup D, Crestani M, Chiang JY. Identification of a bile acid response element in the cholesterol 7α-hydroxylase gene CYP7A. Am J Physiol 1997;273(2 Pt 1):G508-17
   PubMed Web of Science ®Google Scholar
• Chen W, Chiang JY. Regulation of human sterol 27-hydroxylase gene (CYP27A1) by bile acids and hepatocyte nuclear factor 4α (HNF4α). Gene 2003;313:71-82
   PubMed Web of Science ®Google Scholar
• Garuti R, Croce MA, Piccinini L, et al. Functional analysis of the promoter of human sterol 27-hydroxylase gene in HepG2 cells. Gene 2002;283(1-2):133-43
   PubMed Web of Science ®Google Scholar
• Inoue Y, Yu AM, Inoue J, Gonzalez FJ. Hepatocyte nuclear factor 4α is a central regulator of bile acid conjugation. J Biol Chem 2004;279(4):2480-9
   PubMed Web of Science ®Google Scholar
• Makishima M, Okamoto AY, Repa JJ, et al. Identification of a nuclear receptor for bile acids. Science 1999;284(5418):1362-5
   PubMed Web of Science ®Google Scholar
• Goodwin B, Jones SA, Price RR, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000;6(3):517-26
   PubMed Web of Science ®Google Scholar
• Denson LA, Sturm E, Echevarria W, et al. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 2001;121(1):140-7
   PubMed Web of Science ®Google Scholar
• Sinal CJ, Tohkin M, Miyata M, et al. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000;102(6):731-44
   PubMed Web of Science ®Google Scholar
• Holt JA, Luo G, Billin AN, et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 2003;17(13):1581-91
   PubMed Web of Science ®Google Scholar
• Inagaki T, Choi M, Moschetta A, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2005;2(4):217-25
   PubMed Web of Science ®Google Scholar
• Pircher PC, Kitto JL, Petrowski ML, et al. Farnesoid X receptor regulates bile acid-amino acid conjugation. J Biol Chem 2003;278(30):27703-11
   PubMed Web of Science ®Google Scholar
• Staudinger JL, Goodwin B, Jones SA, et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 2001;98(6):3369-74
   PubMed Web of Science ®Google Scholar
• Li T, Chiang JY. Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7α-hydroxylase gene transcription. Am J Physiol 2005;288(1):G74-84
   PubMed Web of Science ®Google Scholar
• Bhalla S, Ozalp C, Fang S, et al. Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1α. Functional implications in hepatic cholesterol and glucose metabolism. J Biol Chem 2004;279(43):45139-47
   PubMed Web of Science ®Google Scholar
• Jung D, Mangelsdorf DJ, Meyer UA. Pregnane X receptor is a target of farnesoid X receptor. J Biol Chem 2006;281(28):19081-91
   PubMed Web of Science ®Google Scholar
• Makishima M, Lu TT, Xie W, et al. Vitamin D receptor as an intestinal bile acid sensor. Science 2002;296(5571):1313-6
   PubMed Web of Science ®Google Scholar
• Eloranta JJ, Kullak-Ublick GA. Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch Biochem Biophys 2005;433(2):397-412
   PubMed Web of Science ®Google Scholar
• Lewis DF. Human P450s in the metabolism of drugs: molecular modelling of enzyme-substrate interactions. Expert Opinion Drug Metab Toxicol 2005;1(1):5-8
   PubMedGoogle Scholar
• Chen D, Park Y, Kemper B. Differential protein binding and transcriptional activities of HNF4 elements in three closely related CYP2C genes. DNA Cell Biol 1994;13:771-9
   PubMed Web of Science ®Google Scholar
• Jover R, Bort R, Gomez-Lechon MJ, Castell JV. Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting. Hepatology 2001;33(3):668-75
   PubMed Web of Science ®Google Scholar
• Corchero J, Granvil CP, Akiyama TE, et al. The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse. Mol Pharmacol 2001;60(6):1260-7
   PubMed Web of Science ®Google Scholar
• Kamiya A, Inoue Y, Gonzalez FJ. Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development. Hepatology 2003;37(6):1375-84
   PubMed Web of Science ®Google Scholar
• Tirona RG, Lee W, Leake BF, et al. The orphan nuclear receptor HNF4α determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 2003;9(2):220-4
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Goodwin B, Willson TM. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 2002;23(5):687-702
   PubMed Web of Science ®Google Scholar
• Goodwin B, Hodgson E, Liddle C. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol 1999;56(6):1329-39
   PubMed Web of Science ®Google Scholar
• Honkakoski P, Sueyoshi T, Negishi M. Drug-activated nuclear receptors CAR and PXR. Ann Med 2003;35(3):172-82
   PubMed Web of Science ®Google Scholar
• Matsubara T, Yoshinari K, Aoyama K, et al. Role of vitamin D receptor in the lithocholic acid-mediated CYP3A induction in vitro and in vivo. Drug Metab Dispos 2008;36(10):2058-63
   PubMed Web of Science ®Google Scholar
• Drocourt L, Ourlin JC, Pascussi JM, et al. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 2002;277(28):25125-32
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Gerbal-Chaloin S, Drocourt L, et al. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 2003;1619(3):243-53
   PubMed Web of Science ®Google Scholar
• Sonoda J, Rosenfeld JM, Xu L, et al. A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection. Current Drug Metab 2003;4(1):59-72
   PubMed Web of Science ®Google Scholar
• Handschin C, Meyer UA. Induction of drug metabolism: the role of nuclear receptors. Pharmacol Rev 2003;55(4):649-73
   PubMed Web of Science ®Google Scholar
• Moore LB, Parks DJ, Jones SA, et al. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 2000;275(20):15122-7
   PubMed Web of Science ®Google Scholar
• Ma X, Idle JR, Gonzalez FJ. The pregnane X receptor: from bench to bedside. Expert Opinion Drug Metab Toxicol 2008;4(7):895-908
   PubMed Web of Science ®Google Scholar
• Kast HR, Goodwin B, Tarr PT, et al. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 2002;277(4):2908-15
   PubMed Web of Science ®Google Scholar
• Xie W, Yeuh MF, Radominska-Pandya A, et al. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci USA 2003;100(7):4150-5
   PubMed Web of Science ®Google Scholar
• Staudinger JL, Madan A, Carol KM, Parkinson A. Regulation of drug transporter gene expression by nuclear receptors. Drug Metab Dispos 2003;31(5):523-7
   PubMed Web of Science ®Google Scholar
• Chen Y, Kissling G, Negishi M, Goldstein JA. The nuclear receptors constitutive androstane receptor and pregnane X receptor cross-talk with hepatic nuclear factor 4alpha to synergistically activate the human CYP2C9 promoter. J Pharmacol Exp Ther 2005;314(3):1125-33
   PubMed Web of Science ®Google Scholar
• Fang HL, Strom SC, Ellis E, et al. Positive and negative regulation of human hepatic hydroxysteroid sulfotransferase (SULT2A1) gene transcription by rifampicin: roles of hepatocyte nuclear factor 4alpha and pregnane X receptor. J Pharmacol Exp Ther 2007;323(2):586-98
   PubMed Web of Science ®Google Scholar
• Wortham M, Czerwinski M, He L, et al. Expression of constitutive androstane receptor, hepatic nuclear factor 4α, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metab Dispos 2007;35(9):1700-10
   PubMed Web of Science ®Google Scholar
• Urquhart BL, Tirona RG, Kim RB. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J Clin Pharmacol 2007;47(5):566-78
   PubMed Web of Science ®Google Scholar
• Makishima M. Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors. J Pharmacol Sci 2005;97(2):177-83
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Rizzo G, Donini A, et al. Targeting farnesoid X receptor for liver and metabolic disorders. Trends Mol Med 2007;13(7):298-309
   PubMed Web of Science ®Google Scholar
• Westin S, Heyman RA, Martin R. FXR, a therapeutic target for bile acid and lipid disorders. Mini Rev Med Chem 2005;5(8):719-27
   PubMed Web of Science ®Google Scholar
• Chen T. Nuclear receptor drug discovery. Current Opin Chem Biol 2008;12(4):418-26
   PubMed Web of Science ®Google Scholar
• Wipf P, Gong H, Janjic JM, et al. New opportunities for pregnane X receptor (PXR) targeting in drug development: lessons from enantio- and species-specific PXR ligands identified from a discovery library of amino acid analogues. Mini Rev Med Chem 2007;7(6):617-25
   PubMed Web of Science ®Google Scholar